NMN (nicotinamide mononucleotide) evidence, 2020
Irie J, Inagaki E, Fujita M, et al., Endocrine Journal, 2020 — single-dose safety and tolerability study of oral NMN
- Grade
- Design
- rct
- Year
- 2020
- Participants
- 10
- Ingredient
- NMN (nicotinamide mononucleotide)
- Goal
- General coverage
Effect
Single oral doses up to 500 mg were tolerated in 10 healthy men; the study measured safety markers only, not efficacy.
Limitations and notes
Editorial reference only.